Published in J Am Chem Soc on March 31, 2010
Septal and lateral wall localization of PBP5, the major D,D-carboxypeptidase of Escherichia coli, requires substrate recognition and membrane attachment. Mol Microbiol (2010) 1.25
Analysis of some common pathogens and their drug resistance to antibiotics. Pak J Med Sci (2013) 0.82
Penicillin-binding protein 5 can form a homo-oligomeric complex in the inner membrane of Escherichia coli. Protein Sci (2011) 0.76
Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J Biomol NMR (1999) 26.99
Torsion angle dynamics for NMR structure calculation with the new program DYANA. J Mol Biol (1997) 15.40
Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation. Biochemistry (1994) 13.94
Backbone dynamics of proteins as studied by 15N inverse detected heteronuclear NMR spectroscopy: application to staphylococcal nuclease. Biochemistry (1989) 10.50
The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. Biochemistry (1992) 9.40
Hydrogen exchange and structural dynamics of proteins and nucleic acids. Q Rev Biophys (1983) 9.14
Genome-wide analysis of integral membrane proteins from eubacterial, archaean, and eukaryotic organisms. Protein Sci (1998) 7.88
Backbone dynamics of Escherichia coli ribonuclease HI: correlations with structure and function in an active enzyme. J Mol Biol (1995) 5.58
The GxxxG motif: a framework for transmembrane helix-helix association. J Mol Biol (2000) 5.09
The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis. FEMS Microbiol Rev (2008) 4.83
Emerging roles for lipids in shaping membrane-protein function. Nature (2009) 4.14
Molecular basis for membrane phospholipid diversity: why are there so many lipids? Annu Rev Biochem (1997) 3.80
Escherichia coli mutants lacking all possible combinations of eight penicillin binding proteins: viability, characteristics, and implications for peptidoglycan synthesis. J Bacteriol (1999) 3.41
Morphogenesis of rod-shaped sacculi. FEMS Microbiol Rev (2008) 2.85
Why and how bacteria localize proteins. Science (2009) 2.73
Penicillin binding proteins: key players in bacterial cell cycle and drug resistance processes. FEMS Microbiol Rev (2006) 2.40
Analysis of the backbone dynamics of interleukin-1 beta using two-dimensional inverse detected heteronuclear 15N-1H NMR spectroscopy. Biochemistry (1990) 2.36
Geometric cue for protein localization in a bacterium. Science (2009) 2.27
Amphipathic helices and membrane curvature. FEBS Lett (2009) 2.23
Penicillin binding protein 5 affects cell diameter, contour, and morphology of Escherichia coli. J Bacteriol (2000) 1.97
Low-conductivity buffers for high-sensitivity NMR measurements. J Am Chem Soc (2002) 1.88
Contributions of PBP 5 and DD-carboxypeptidase penicillin binding proteins to maintenance of cell shape in Escherichia coli. J Bacteriol (2001) 1.78
Lipid domains in bacterial membranes. Mol Microbiol (2006) 1.77
Differential roles of ionic, aliphatic, and aromatic residues in membrane-protein interactions: a surface plasmon resonance study on phospholipases A2. Biochemistry (2001) 1.69
Cardiolipin promotes polar localization of osmosensory transporter ProP in Escherichia coli. Mol Microbiol (2007) 1.66
Ferrichrome-A tetrahydrate. Determination of crystal and molecular structure. J Am Chem Soc (1966) 1.66
Direct quantitation of the number of individual penicillin-binding proteins per cell in Escherichia coli. J Bacteriol (1996) 1.57
Structure of outer membrane protein G by solution NMR spectroscopy. Proc Natl Acad Sci U S A (2007) 1.56
Crystal structure of the membrane-bound bifunctional transglycosylase PBP1b from Escherichia coli. Proc Natl Acad Sci U S A (2009) 1.55
FtsZ directs a second mode of peptidoglycan synthesis in Escherichia coli. J Bacteriol (2007) 1.54
Coarse-grained molecular dynamics simulations of the energetics of helix insertion into a lipid bilayer. Biochemistry (2008) 1.51
Two distinct transpeptidation reactions during murein synthesis in Escherichia coli. J Bacteriol (1987) 1.50
Size and shape of detergent micelles determined by small-angle X-ray scattering. J Phys Chem B (2007) 1.49
Phosphatidylethanolamine domains and localization of phospholipid synthases in Bacillus subtilis membranes. J Bacteriol (2005) 1.43
Physiological functions of D-alanine carboxypeptidases in Escherichia coli. Trends Microbiol (2008) 1.39
Interfacial folding and membrane insertion of a designed helical peptide. Biochemistry (2004) 1.38
The C terminus of penicillin-binding protein 5 is essential for localisation to the E. coli inner membrane. EMBO J (1986) 1.31
Daughter cell separation by penicillin-binding proteins and peptidoglycan amidases in Escherichia coli. J Bacteriol (2006) 1.30
An 18 amino acid amphiphilic helix forms the membrane-anchoring domain of the Escherichia coli penicillin-binding protein 5. Mol Microbiol (1987) 1.27
Lipid localization in bacterial cells through curvature-mediated microphase separation. Biophys J (2008) 1.25
The molecular basis of the differential subcellular localization of FYVE domains. J Biol Chem (2004) 1.23
Binding of amphiphilic peptides to phospholipid/cholesterol unilamellar vesicles: a model for protein--cholesterol interaction. Proc Natl Acad Sci U S A (1981) 1.15
Crystal structure of penicillin binding protein 4 (dacB) from Escherichia coli, both in the native form and covalently linked to various antibiotics. Biochemistry (2006) 1.13
Phosphatidic acid and N-acylphosphatidylethanolamine form membrane domains in Escherichia coli mutant lacking cardiolipin and phosphatidylglycerol. J Biol Chem (2008) 1.12
Contribution of membrane-binding and enzymatic domains of penicillin binding protein 5 to maintenance of uniform cellular morphology of Escherichia coli. J Bacteriol (2002) 1.12
Cardiolipin controls the osmotic stress response and the subcellular location of transporter ProP in Escherichia coli. J Biol Chem (2008) 1.02
Catalytic mechanism of penicillin-binding protein 5 of Escherichia coli. Biochemistry (2007) 1.02
Topology of an outer-membrane enzyme: Measuring oxygen and water contacts in solution NMR studies of PagP. J Am Chem Soc (2006) 1.01
Proteome of the Escherichia coli envelope and technological challenges in membrane proteome analysis. Biochim Biophys Acta (2007) 0.98
Exploring the inner membrane proteome of Escherichia coli: which proteins are eluding detection and why? Trends Microbiol (2009) 0.97
Antimicrobial peptide RP-1 structure and interactions with anionic versus zwitterionic micelles. Biopolymers (2009) 0.96
pH, inhibitor, and substrate specificity studies on Escherichia coli penicillin-binding protein 5. Biochim Biophys Acta (2002) 0.95
Toward a hyperstructure taxonomy. Annu Rev Microbiol (2007) 0.94
Subcellular localization of Escherichia coli osmosensory transporter ProP: focus on cardiolipin membrane domains. Mol Microbiol (2007) 0.93
Crystal structure of a peptidoglycan synthesis regulatory factor (PBP3) from Streptococcus pneumoniae. J Biol Chem (2004) 0.91
Sequences near the active site in chimeric penicillin binding proteins 5 and 6 affect uniform morphology of Escherichia coli. J Bacteriol (2003) 0.90
Deletion of penicillin-binding protein 5 (PBP5) sensitises Escherichia coli cells to beta-lactam agents. Int J Antimicrob Agents (2010) 0.90
Alpha-helical conformation in the C-terminal anchoring domains of E. coli penicillin-binding proteins 4, 5 and 6. Biochim Biophys Acta (1997) 0.84
pH-induced insertion of the amphiphilic alpha-helical anchor of Escherichia coli penicillin-binding protein 5. Eur J Biochem (1990) 0.83
An investigation into the lipid interactions of peptides corresponding to the C-terminal anchoring domains of Escherichia coli penicillin-binding proteins 4, 5 and 6. Biochim Biophys Acta (1998) 0.81
Membrane interaction of Escherichia coli penicillin binding protein 5 is modulated by the ectomembranous domain. FEBS Lett (1993) 0.80
A study on the C-terminal membrane anchoring of Escherichia coli penicillin-binding protein 5. Biochem Biophys Res Commun (2002) 0.76
Investigation into the lipid requirement for the membrane anchoring of Escherichia coli penicillin binding protein 5. Biochem Soc Trans (1995) 0.76
Identification of a membrane interactive protein anchor. Biochem Soc Trans (1993) 0.76
Cytoplasmic-membrane anchoring of a class A beta-lactamase and its capacity in manifesting antibiotic resistance. Antimicrob Agents Chemother (2007) 0.76
Depletion of anionic phospholipids has no observable effect on the anchoring of penicillin binding protein 5 to the inner membrane of Escherichia coli. FEMS Microbiol Lett (1995) 0.76
Investigation into structural features of the Escherichia coli penicillin-binding protein 5 C-terminal anchor. Biochem Soc Trans (1990) 0.76
An investigation into the ability of C-terminal homologues of Escherichia coli low molecular mass penicillin-binding proteins 4, 5 and 6 to undergo membrane interaction. Biochimie (1997) 0.76
Normal mode paths for hydrogen exchange in the peptide ferrichrome. Proc Natl Acad Sci U S A (1983) 0.76
The possible involvement of anionic phospholipids in the anchoring of penicillin binding protein 5 to the inner membrane of Escerichia coli. Biochem Soc Trans (1995) 0.76
Bacterial resistance to beta-lactam antibiotics: compelling opportunism, compelling opportunity. Chem Rev (2005) 4.48
Tackling antibiotic resistance. Nat Rev Microbiol (2011) 3.95
Versatility of aminoglycosides and prospects for their future. Clin Microbiol Rev (2003) 3.72
Three-dimensional structure of the bacterial cell wall peptidoglycan. Proc Natl Acad Sci U S A (2006) 2.81
A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J Neurosci (2005) 2.54
Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from gram-negative bacteria. Annu Rev Microbiol (2011) 2.53
Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic background. Cancer Res (2008) 1.88
Potent mechanism-based inhibitors for matrix metalloproteinases. J Biol Chem (2005) 1.83
How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function. Proc Natl Acad Sci U S A (2013) 1.75
The basis for resistance to beta-lactam antibiotics by penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus. J Biol Chem (2004) 1.74
Ab initio QM/MM study of class A beta-lactamase acylation: dual participation of Glu166 and Lys73 in a concerted base promotion of Ser70. J Am Chem Soc (2005) 1.67
Recent advances in MMP inhibitor design. Cancer Metastasis Rev (2006) 1.66
Dithiocarbamate assembly on gold. J Am Chem Soc (2005) 1.64
Bacterial cell-wall recycling. Ann N Y Acad Sci (2012) 1.60
Molecular basis and phenotype of methicillin resistance in Staphylococcus aureus and insights into new beta-lactams that meet the challenge. Antimicrob Agents Chemother (2009) 1.51
Design and characterization of a metalloproteinase inhibitor-tethered resin for the detection of active MMPs in biological samples. Chem Biol (2006) 1.50
Co-opting the cell wall in fighting methicillin-resistant Staphylococcus aureus: potent inhibition of PBP 2a by two anti-MRSA beta-lactam antibiotics. J Am Chem Soc (2008) 1.50
Cell surface association of matrix metalloproteinase-9 (gelatinase B). Cancer Metastasis Rev (2003) 1.45
Aminoglycosides modified by resistance enzymes display diminished binding to the bacterial ribosomal aminoacyl-tRNA site. Chem Biol (2002) 1.42
Resistance to beta-lactam antibiotics and its mediation by the sensor domain of the transmembrane BlaR signaling pathway in Staphylococcus aureus. J Biol Chem (2003) 1.38
The future of the β-lactams. Curr Opin Microbiol (2010) 1.36
Antimetastatic activity of a novel mechanism-based gelatinase inhibitor. Cancer Res (2005) 1.36
High-resolution X-ray structure of an acyl-enzyme species for the class D OXA-10 beta-lactamase. J Am Chem Soc (2002) 1.36
Synthetic peptidoglycan substrates for penicillin-binding protein 5 of Gram-negative bacteria. J Org Chem (2004) 1.33
Structural consequences of the inhibitor-resistant Ser130Gly substitution in TEM beta-lactamase. Biochemistry (2005) 1.32
Inhibition of human prostate cancer growth, osteolysis and angiogenesis in a bone metastasis model by a novel mechanism-based selective gelatinase inhibitor. Int J Cancer (2006) 1.32
Bacterial AmpD at the crossroads of peptidoglycan recycling and manifestation of antibiotic resistance. J Am Chem Soc (2009) 1.31
Activation of BlaR1 protein of methicillin-resistant Staphylococcus aureus, its proteolytic processing, and recovery from induction of resistance. J Biol Chem (2011) 1.30
Structure and compatibility of a magnesium electrolyte with a sulphur cathode. Nat Commun (2011) 1.30
Mechanistic characterization of the bifunctional aminoglycoside-modifying enzyme AAC(3)-Ib/AAC(6')-Ib' from Pseudomonas aeruginosa. Biochemistry (2007) 1.28
Mechanistic basis for the emergence of catalytic competence against carbapenem antibiotics by the GES family of beta-lactamases. J Biol Chem (2009) 1.28
Iminonitroso Diels-Alder reactions for efficient derivatization and functionalization of complex diene-containing natural products. Org Lett (2007) 1.28
Discoidin domain receptors: unique receptor tyrosine kinases in collagen-mediated signaling. J Biol Chem (2013) 1.27
Structural insights into the bactericidal mechanism of human peptidoglycan recognition proteins. Proc Natl Acad Sci U S A (2007) 1.27
Extracellular proteases as targets for treatment of cancer metastases. Chem Soc Rev (2004) 1.26
Characterization of the bifunctional aminoglycoside-modifying enzyme ANT(3'')-Ii/AAC(6')-IId from Serratia marcescens. Biochemistry (2006) 1.25
Mechanism of anchoring of OmpA protein to the cell wall peptidoglycan of the gram-negative bacterial outer membrane. FASEB J (2011) 1.25
Design of novel antibiotics that bind to the ribosomal acyltransfer site. J Am Chem Soc (2002) 1.23
Mutational replacement of Leu-293 in the class C Enterobacter cloacae P99 beta-lactamase confers increased MIC of cefepime. Antimicrob Agents Chemother (2002) 1.23
The importance of a critical protonation state and the fate of the catalytic steps in class A beta-lactamases and penicillin-binding proteins. J Biol Chem (2004) 1.22
Activation for catalysis of penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus by bacterial cell wall. J Am Chem Soc (2005) 1.22
Reactions of all Escherichia coli lytic transglycosylases with bacterial cell wall. J Am Chem Soc (2013) 1.21
Source of phosphate in the enzymic reaction as a point of distinction among aminoglycoside 2''-phosphotransferases. J Biol Chem (2009) 1.21
Lytic transglycosylase MltB of Escherichia coli and its role in recycling of peptidoglycan strands of bacterial cell wall. J Am Chem Soc (2008) 1.21
Synthesis of a fragment of bacterial cell wall. J Org Chem (2004) 1.20
Inhibition of histone deacetylases: a pharmacological approach to the treatment of non-cancer disorders. Curr Top Med Chem (2009) 1.20
Total synthesis of N-acetylglucosamine-1,6-anhydro-N-acetylmuramylpentapeptide and evaluation of its turnover by AmpD from Escherichia coli. J Am Chem Soc (2009) 1.19
Molecular structures and dynamics of the stepwise activation mechanism of a matrix metalloproteinase zymogen: challenging the cysteine switch dogma. J Am Chem Soc (2007) 1.19
The complex of a designer antibiotic with a model aminoacyl site of the 30S ribosomal subunit revealed by X-ray crystallography. J Am Chem Soc (2003) 1.18
Messenger functions of the bacterial cell wall-derived muropeptides. Biochemistry (2012) 1.17
Three decades of the class A beta-lactamase acyl-enzyme. Curr Protein Pept Sci (2009) 1.17
Discrete steps in sensing of beta-lactam antibiotics by the BlaR1 protein of the methicillin-resistant Staphylococcus aureus bacterium. Proc Natl Acad Sci U S A (2006) 1.17
X-ray crystal structure of the acylated beta-lactam sensor domain of BlaR1 from Staphylococcus aureus and the mechanism of receptor activation for signal transduction. J Am Chem Soc (2004) 1.15
Synthetic peptidoglycan motifs for germination of bacterial spores. Chembiochem (2010) 1.12
Complex pattern of membrane type 1 matrix metalloproteinase shedding. Regulation by autocatalytic cells surface inactivation of active enzyme. J Biol Chem (2002) 1.12
Active site ring-opening of a thiirane moiety and picomolar inhibition of gelatinases. Chem Biol Drug Des (2009) 1.11
Disruption of allosteric response as an unprecedented mechanism of resistance to antibiotics. J Am Chem Soc (2014) 1.11
Roles of matrix metalloproteinases in flow-induced outward vascular remodeling. J Cereb Blood Flow Metab (2009) 1.10
Metabolism of a highly selective gelatinase inhibitor generates active metabolite. Chem Biol Drug Des (2007) 1.10
Discovery of a new class of non-β-lactam inhibitors of penicillin-binding proteins with Gram-positive antibacterial activity. J Am Chem Soc (2014) 1.10
Pharmacological stabilization of intracranial aneurysms in mice: a feasibility study. Stroke (2012) 1.10
Inhibition of MMP-9 by a selective gelatinase inhibitor protects neurovasculature from embolic focal cerebral ischemia. Mol Neurodegener (2012) 1.10
Prostate cancer-associated membrane type 1-matrix metalloproteinase: a pivotal role in bone response and intraosseous tumor growth. Am J Pathol (2007) 1.09
Insertion of epicatechin gallate into the cytoplasmic membrane of methicillin-resistant Staphylococcus aureus disrupts penicillin-binding protein (PBP) 2a-mediated beta-lactam resistance by delocalizing PBP2. J Biol Chem (2010) 1.09
Molecular dynamics at the root of expansion of function in the M69L inhibitor-resistant TEM beta-lactamase from Escherichia coli. J Am Chem Soc (2002) 1.08
Synthesis of chiral 2-(4-phenoxyphenylsulfonylmethyl)thiiranes as selective gelatinase inhibitors. Org Lett (2005) 1.08
Short alkylated peptoid mimics of antimicrobial lipopeptides. Antimicrob Agents Chemother (2010) 1.08
Structural basis for carbapenemase activity of the OXA-23 β-lactamase from Acinetobacter baumannii. Chem Biol (2013) 1.08
Pronounced diversity in electronic and chemical properties between the catalytic zinc sites of tumor necrosis factor-alpha-converting enzyme and matrix metalloproteinases despite their high structural similarity. J Biol Chem (2004) 1.07
A practical synthesis of nitrocefin. J Org Chem (2005) 1.07
Reactions of the three AmpD enzymes of Pseudomonas aeruginosa. J Am Chem Soc (2013) 1.06
Elucidation of the molecular recognition of bacterial cell wall by modular pneumococcal phage endolysin CPL-1. J Biol Chem (2007) 1.06
Crystal structures of penicillin-binding protein 6 from Escherichia coli. J Am Chem Soc (2009) 1.05
Design, synthesis, and characterization of potent, slow-binding inhibitors that are selective for gelatinases. J Biol Chem (2002) 1.04
Matrix metalloproteinase 2 inhibition: combined quantum mechanics and molecular mechanics studies of the inhibition mechanism of (4-phenoxyphenylsulfonyl)methylthiirane and its oxirane analogue. Biochemistry (2009) 1.04
Lysine N(zeta)-decarboxylation in the BlaR1 protein from Staphylococcus aureus at the root of its function as an antibiotic sensor. J Am Chem Soc (2007) 1.03
Phosphoryl transfer by aminoglycoside 3'-phosphotransferases and manifestation of antibiotic resistance. Bioorg Chem (2004) 1.03
Kinetic mechanism of enterococcal aminoglycoside phosphotransferase 2"-Ib. Biochemistry (2007) 1.02
Effect of synthetic matrix metalloproteinase inhibitors on lipopolysaccharide-induced blood-brain barrier opening in rodents: Differences in response based on strains and solvents. Brain Res (2006) 1.02
Catalytic mechanism of penicillin-binding protein 5 of Escherichia coli. Biochemistry (2007) 1.02